PrEP: A case study

Journal of the American Association of Nurse Practitioners
Stefan Rowniak

Abstract

The purpose of this case study is to present information and raise awareness about the provision of pre-exposure prophylaxis (PrEP) to those individuals who are at risk for HIV infection. PubMed, CINAHL, government websites, press releases, and the author's clinical experiences. PrEP is the latest tool available for HIV prevention that has been approved by the FDA. It involves taking the HIV medication TDF/FTC on a daily basis. Documented side effects are minimal but renal monitoring is recommended because of possible kidney damage. PrEP may provide as much as 90% protection against HIV infection, but this is dependent upon patient compliance. Nurse practitioners are in an ideal position to be the gatekeepers for information and access to PrEP. However, this requires that they engage in thorough risk assessments with their patients. This includes both a comprehensive sexual history and drug use history. The case study demonstrates the importance of intervention in and recognition of high-risk stigmatized populations such as transgender individuals and that prompt action may prevent future HIV infections.

References

Oct 15, 2003·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Mike Youle, Mark A Wainberg
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michelle E RolandJeffrey N Martin
Jun 10, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Supriya D MehtaEmily J Erbelding
Jan 2, 2007·Current Opinion in Infectious Diseases·Michelle E Roland
Aug 19, 2007·AIDS and Behavior·Jeffrey H HerbstUNKNOWN HIV/AIDS Prevention Research Synthesis Team
Jan 3, 2009·The Journal of the Association of Nurses in AIDS Care : JANAC·Stefan Rowniak
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Jan 4, 2013·American Journal of Preventive Medicine·Stephanie E CohenSusan Philip
Jul 20, 2014·JAMA : the Journal of the American Medical Association·Anna Satcher JohnsonJonathan Mermin

❮ Previous
Next ❯

Citations

Mar 11, 2020·Journal of Clinical Nursing·Carmel KellyMaria Lohan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Xiaoyi YangHao Liang
Medicina clínica
José Vicente Fernández-Montero, Vicente Soriano
JAMA : the Journal of the American Medical Association
Robert Steinbrook
© 2022 Meta ULC. All rights reserved